SciMed Solutions

To explore how T-cell receptor therapies are reshaping cancer immunotherapy, we spoke with Dr. Joanna Brewer, Chief Scientific Officer of Adaptimmune, on a prior episode of the SciMed Biotech Podcast.

Dr. Brewer walks through how Adaptimmune’s work on SPEAR T-cell therapies is designed to leverage engineered T-cell receptors to target cancer-specific peptides, and what it takes to translate these approaches from discovery into clinical programs. We discuss the development of TCR-based cell therapies, lessons from patient outcomes, and how translational research shapes next-generation approaches in the field.

For listeners interested in the mechanics, challenges, and future direction of cell therapy in oncology, this episode offers a clear and research-driven perspective from someone deeply embedded in the science.

Listen on the SciMed website.

🎧 https://scimed.io/news/joanna-brewer-scimed-biotech-podcast

SciMed Biotech Podcast with Joanna Brewer of Adaptimmune — SciMed Brace yourself for an exhilarating journey into the world of cutting-edge cancer immunotherapy with Dr. Joanna Brewer, Chief Scientific Officer of Adaptimmune!

In a prior episode of the SciMed Biotech Podcast, we spoke with Paul Marshall, CEO of Rapid Fluidics, about how microfluidics development can be dramatically accelerated without sacrificing precision.

Paul shares how advances in rapid prototyping, 3D printing, and CAD-driven design are changing the way microfluidic devices are built—reducing development timelines and costs that traditionally slow life science and biotech innovation.

We discuss why speed matters so much in early-stage product development, how design iteration impacts downstream scalability, and what engineers and founders should consider when moving from concept to functional device.

For anyone working at the intersection of engineering and biotech, this episode offers a practical look at how microfluidics can move faster—and smarter.

Listen now on our website.

🔗 https://scimed.io/news/paul-marshall-rapid-fluidics

SciMed Biotech Podcast with Paul Marshall of Rapid Fluidics — SciMed In this episode of the SciMed Biotech Podcast , we're joined by Paul Marshall , a trailblazer in the field of microfluidics and the CEO of Rapid Fluidics . Paul shares his journey from an engineering consultant to leading a company at the forefront of microfluidic technology. With his deep expert

Today’s guest on the SciMed Biotech Podcast is Keerthy Sunder, Chief Medical Officer of Karma Doctors & Associates and a leading researcher in neuromodulation, TMS, and integrative psychiatry.

In this episode, Dr. Sunder breaks down why current psychiatric standards — reducing depression or anxiety scores — don’t fully capture brain health or long-term outcomes. He outlines a model that combines evidence-based neuromodulation, metabolic and hormonal factors, neuroplasticity, and behavioral science to address treatment-resistant conditions and optimize cognitive function.

We dive into:

👨‍⚕️ Where traditional psychiatry falls short in treatment-resistant patients
🤖 The mechanistic role of TMS and neurofeedback in reshaping neural circuits
🧠 The gut-brain and hormone-brain pathways that influence mood and cognition

If you’re interested in how psychiatry is evolving, this conversation is worth a listen.

Listen now on the SciMed website: https://www.scimed.io/news/keerthy-sunder